Global Intravenous Solutions Market Projected to Grow at 8% CAGR, Reaching $20.51 Billion by 2029

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts

What Will the Intravenous Solutions Industry Market Size Be by 2025?
The market for intravenous solutions has been witnessing a robust growth in the past few years. The market is expected to expand from $14 billion in 2024 to $15.05 billion in 2025, with a compound annual growth rate (CAGR) of 7.5%. Factors that contributed to the growth during the historical period include an increase in surgical procedures, a rise in chronic disease prevalence, the expansion of home healthcare, strict regulations to guarantee product safety, an enhanced focus on patient hydration, and initiatives for global emergency preparedness.

What's the Long-Term Growth Forecast for the Intravenous Solutions Market Size Through 2029?
Expectations for the intravenous solutions market suggest strong growth in the approaching years. The growth is projected to peak at $20.51 billion in 2029, with a compound annual growth rate (CAGR) of 8.0%. Factors contributing to this predicted growth in the forecast period include population expansion and aging, an escalation in surgical interventions, an upsurge in infectious diseases, advancements in telemedicine and remote patient monitoring, emphasis on preventive healthcare, global health security investments, and patient-oriented care trends. Significant trends during this forecasting period comprise of heightened demand for parenteral nutrition solutions, an increase in the acceptance of pre-mixed iv solutions, growth of home infusion therapies, the advent of electrolyte-balanced solutions, the introduction of innovative drug additives and adjuncts, and the implementation of intelligent iv systems for monitoring.

View the full report here:
https://www.thebusinessresearchcompany.com/report/intravenous-solutions-global-market-report

What Are the Key Growth Drivers Fueling the Intravenous Solutions Market Expansion?
The growing instances of cancer are anticipated to kindle the development of the intravenous solutions market. As a collective of illnesses featuring unchecked cell expansion and the potential to infiltrate nearby tissues and distribute to other body parts, cancer commonly employs intravenous solutions in its treatment. These solutions are used to administer chemotherapy drugs and retain hydration throughout the therapy. For instance, the World Health Organization predicted in February 2024 that by 2050, there would be more than 35 million new cancer cases, a 77% growth in comparison with the projected 20 million cases in 2022. Thus, the escalating prevalence of cancer is spurring the growth of the intravenous solutions market. Key Driver in Intravenous Solutions Market: Growing Number of Surgeries Fuels Market Expansion

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13465&type=smp

What Are the Key Trends Driving Intravenous Solutions Market Growth?
Prominent companies in the intravenous solutions market are striving for innovation in the creation of novel syringes, such as pre-filled and ready-to-use syringes, to carve a niche for themselves in this competitive market. These syringes come already loaded with medication, eliminating the need for manual filling or preparation and facilitating immediate usage. An illustrative example of this can be seen in GENIXUS Corp., a US-based healthcare firm that unveiled KinetiXTM Rocuronium Bromide Injection in 5 mL and 10 mL ready-to-use (RTA) syringes in August 2023. These syringes are crafted out of a clear, sturdy polymer material that mitigates potential risks with glass syringes. With these pre-filled syringes ready for instant administration, both time and chances of medication errors are significantly reduced. The injection of rocuronium bromide is solely for intravenous use. It boasts numerous crucial features like being RFID-enabled with KitCheck, a state-of-the-art kit and tray management technology. Other features are its intuitive labeling and a color-coded plunger rod designed to assist quick identification.

How Is the Intravenous Solutions Market Segmented?
The intravenous solutions market covered in this report is segmented -

1) By Product: Total Parenteral Nutrition, Peripheral Parenteral Nutrition
2) By Nutrients: Carbohydrates, Vitamins And Minerals, Single Dose Amino Acids, Parenteral Lipid Emulsion, Other Nutrients
3) By Application: Basic Intravenous (IV) Solution, Nutritional Intravenous (IV) Solution, Blood Intravenous (IV) Solution, Drug Intravenous (IV) Solution, Irrigation Intravenous (IV) Solution
4) By End User: Hospitals, Clinics, Ambulatory Surgery Centers, Home Care Settings

Subsegments:
1) By Total Parenteral Nutrition (TPN): Carbohydrate Solutions, Amino Acid Solutions, Lipid Solutions, Electrolyte Solutions, Multivitamin Solutions
2) By Peripheral Parenteral Nutrition (PPN): Carbohydrate Solutions, Amino Acid Solutions, Lipid Solutions, Electrolyte Solutions

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=13465&type=smp

Which Companies Are Leading the Charge in Intravenous Solutions Market Innovation?
Major companies operating in the intravenous solutions market report are Pfizer Inc., Abbott Laboratories, Eli Lilly and Company, Fresenius SE & Co. KGaA, Becton, Dickinson and Company, Baxter International Inc., Otsuka Pharmaceutical Co. Ltd., CSL Limited, B. Braun Melsungen AG, Grifols S.A., Terumo Corporation, Nipro Corporation, Sichuan Kelun Pharmaceutical Co. Ltd., Cipla Limited, Hikma Pharmaceuticals PLC, ICU Medical Inc., Gland Pharma Limited, Cisen Pharmaceutical Co. Ltd., Amsino International Inc., JW Life Science Co. Ltd., Eurolife Healthcare Pvt. Ltd., Huaren Pharmaceutical Co. Ltd., Troikaa Pharmaceuticals Ltd., Claris Lifesciences Limited, Amanta Healthcare Ltd., Axa Parenterals Ltd., Wockhardt Ltd., Liqvor pharmaceuticals cjsc, Soxa Formulations & Research Pvt.Ltd., Aculife Healthcare Pvt. Ltd.

Which Regions Are Leading the Global Intravenous Solutions Market in Revenue?
North America was the largest region in the intravenous solutions market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the intravenous solutions market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13465

"This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work."

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.